title: Idiopathic hepatitis B surface antibody seroreversion after pegylated interferon alpha-2a therapy.
authors.forename: Donald N
authors.initials: DN
authors.lastname: Tsynman
authors.forename: Rene
authors.initials: R
authors.lastname: Rivera
authors.forename: Benedict
authors.initials: B
authors.lastname: Maliakkal
mesh_terms: D000328:Adult; D000998:Antiviral Agents / Q000627:therapeutic use*; D006510:Hepatitis B Antibodies / Q000097:blood; D006514:Hepatitis B Surface Antigens / Q000276:immunology; D019694:Hepatitis B, Chronic / Q000188:drug therapy*; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D008297:Male; D011092:Polyethylene Glycols / Q000627:therapeutic use*; D011994:Recombinant Proteins / Q000627:therapeutic use
chemical_list: D000998:Antiviral Agents; D006510:Hepatitis B Antibodies; D006514:Hepatitis B Surface Antigens; D016898:Interferon-alpha; D011994:Recombinant Proteins; D011092:Polyethylene Glycols; C100416:peginterferon alfa-2a